mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma']
#aacr23 is in the headlines: reports on clinical trial results at the aacr annual meeting that found a personalized mrna cancer vaccine combined with immunotherapy may prolong recurrence-free survival in patients with high-risk melanoma. 
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.